Xencor Inc (XNCR) Financial Statements
Industry: Pharmaceutical Preparations
In fiscal 2025, Xencor reported revenue of $125.6M, up 13.7% from $110.5M the year before. Net income was -$91.9M (a -73.2% net margin), or -$1.24 per diluted share. Operating margin was -141.4%. Operating activities generated -$135.1M of cash, leaving -$138.3M of free cash flow. At fiscal year end, Xencor held $875.5M in total assets against $239.9M in total liabilities, including $54.1M of cash and equivalents.
Open the full interactive Xencor financials → Quarterly statements, key ratios, valuation history and price charts.
Xencor Key Stats
| Share Price | $23.52 |
|---|---|
| Market Cap | $1.78B |
| Revenue YoY Growth | +13.7% |
| 52-Week Range | $10.41 – $29.30 |
| Shares Outstanding | 75.9 million (basic, 2026 Q2) |
Xencor Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $122.7M | $275.1M | $164.6M | $168.3M | $110.5M | $125.6M |
| Operating Income | -$76.8M | $43.8M | -$82.5M | -$138.6M | -$178.4M | -$177.5M |
| Pre-Tax Income | -$69.3M | $82.6M | -$54.5M | -$120.4M | -$234.9M | -$89.6M |
| Income Tax | $0 | $0 | $673,000 | $5.8M | $1.6M | $2.5M |
| Net Income | -$69.3M | $82.6M | -$55.2M | -$126.1M | -$232.6M | -$91.9M |
| Diluted EPS | -$1.21 | $1.37 | -$0.93 | -$2.08 | -$3.58 | -$1.24 |
Xencor Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $21.0M | $28.2M | $4.5M | $51.2M |
| Net Income | -$6.0M | -$6.7M | -$128.9M | -$21.7M |
| Diluted EPS | -$0.08 | -$0.09 | -$1.71 | -$0.29 |
Xencor Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $163.5M | $143.5M | $53.9M | $53.8M | $40.9M | $54.1M |
| Current Assets | $637.7M | $424.4M | $675.3M | $623.2M | $577.6M | $599.8M |
| Total Assets | $703.2M | $838.2M | $846.3M | $952.7M | $951.9M | $875.5M |
| Current Liabilities | $121.1M | $70.7M | $63.8M | $84.7M | $87.4M | $95.9M |
| Total Long-Term Debt | — | — | — | $14.6M | $115.2M | $76.5M |
| Total Liabilities | $130.8M | $104.7M | $118.8M | $283.6M | $277.9M | $239.9M |
| Shareholders' Equity | $572.4M | $733.5M | $727.5M | $668.8M | $677.6M | $635.6M |
Xencor Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$5.0M | -$16.9M | $24.5M | $85.1M | -$202.2M | -$135.1M |
| Cash From Investing | $100.2M | -$46.2M | -$119.7M | -$111.1M | -$7.9M | $140.0M |
| Cash From Financing | $18.0M | $43.0M | $5.7M | $26.2M | $197.2M | $8.2M |
| Free Cash Flow | -$15.5M | -$30.2M | -$14.0M | $66.7M | -$208.3M | -$138.3M |
Figures from Xencor's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Xencor financials page for every line item.
Xencor Company Profile
| Ticker | XNCR |
|---|---|
| Exchange | Nasdaq |
| Industry | Pharmaceutical Preparations |
| Headquarters | Pasadena, California |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Accelerated filer |
| SEC CIK | 0001326732 |
Frequently Asked Questions
What was Xencor's revenue in fiscal 2025?
Xencor (XNCR) reported revenue of $125.6M for fiscal 2025.
What is Xencor's annual revenue history?
Xencor's annual revenue by fiscal year: 2020: $122.7M; 2021: $275.1M; 2022: $164.6M; 2023: $168.3M; 2024: $110.5M; 2025: $125.6M.
What was Xencor's net income in fiscal 2025?
Xencor reported net income of -$91.9M for fiscal 2025.
What was Xencor's earnings per share (EPS) in fiscal 2025?
Xencor's diluted EPS was -$1.24 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Xencor generate in fiscal 2025?
Xencor generated -$138.3M of free cash flow in fiscal 2025.
What was Xencor's revenue last quarter?
In its most recent reported quarter (2026 Q2), Xencor reported revenue of $51.2M.
How much debt does Xencor have?
Xencor reported $76.5M of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of Xencor are outstanding?
Xencor reported a weighted average of 75.9 million basic shares outstanding in 2026 Q2.
What is Xencor's market cap?
Based on its latest closing price, Xencor (XNCR) has a market capitalization of about $1.78B.
When does Xencor's fiscal year end?
Xencor's fiscal year end, as registered with the SEC, is December 31.
Where is Xencor headquartered?
Xencor lists its business address in Pasadena, California in its SEC filings.